Retroviral vectors for clinical immunogene therapy are stable for up to 9 years
Lamers, C H J, van Elzakker, P, Luider, B A, van Steenbergen, S C L, Sleijfer, S, Debets, R, Gratama, J WVolume:
15
Year:
2008
Language:
english
Pages:
7
DOI:
10.1038/sj.cgt.7701114
File:
PDF, 170 KB
english, 2008